Klaus Hartmuth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Klaus Hartmuth has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Reinhard Lührmann
Emeritus Group Cellular Biochemistry, Max Planck Institute for Multidisciplinary Sciences, Am Fassberg 11, Göttingen, Germany
3 shared publications Eric Westhof
Architecture et Réactivité de l'ARN, Institut de Biologie Moléculaire et Cellulaire du CNRS, Université de Strasbourg, Strasbourg, France
2 shared publicationsBerthold Kastner
Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, D-37077 Göttingen, Germany
1 shared publicationBritta M Rhode
Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
1 shared publicationCindy L. Will
Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, D-37077 Göttingen, Germany
1 shared publicationCyrille Girard
Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, D-37077 Göttingen, Germany
1 shared publication
Latest Publications
- Open Access
- 3 September 2013
- Published by Springer Nature in The EMBO Journal
- Vol. 32 (21) , 2804-2818
RNA structure analysis of human spliceosomes reveals a compact 3D arrangement of snRNAs at the catalytic core
Although U snRNAs play essential roles in splicing, little is known about the 3D arrangement of U2, U6, and U5 snRNAs and the pre‐mRNA in active spliceosomes. To elucidate their relative spatial organization and dynamic rearrangement, we examined the RNA structure of affinity‐purified, human spliceosomes before and after catalytic step 1 by chemical RNA structure probing. We found a stable 3‐way junction of the U2/U6 snRNA duplex in active spliceosomes that persists minimally through step 1. Moreover, the formation of alternating, mutually exclusive, U2 snRNA conformations, as observed in yeast, was not detected in different assembly stages of human spliceosomal complexes (that is, B, Bact, or C complexes). Psoralen crosslinking revealed an interaction during/after step 1 between internal loop 1 of the U5 snRNA, and intron nucleotides immediately downstream of the branchpoint. Using the experimentally derived structural constraints, we generated a model of the RNA network of the step 1 spliceosome, based on the crystal structure of a group II intron through homology modelling. The model is topologically consistent with current genetic, biochemical, and structural data. There is a [Have you seen?][1] (October 2013) associated with this Article. [1]: http://dx.doi.org/10.1038/emboj.2013.213
- 3 September 2013
- Published by Springer Nature in The EMBO Journal
- Vol. 32 (21) , 2804-2818
Open AccessRNA structure analysis of human spliceosomes reveals a compact 3D arrangement of snRNAs at the catalytic core
Although U snRNAs play essential roles in splicing, little is known about the 3D arrangement of U2, U6, and U5 snRNAs and the pre‐mRNA in active spliceosomes. To elucidate their relative spatial organization and dynamic rearrangement, we examined the RNA structure of affinity‐purified, human spliceosomes before and after catalytic step 1 by chemical RNA structure probing. We found a stable 3‐way junction of the U2/U6 snRNA duplex in active spliceosomes that persists minimally through step 1. Moreover, the formation of alternating, mutually exclusive, U2 snRNA conformations, as observed in yeast, was not detected in different assembly stages of human spliceosomal complexes (that is, B, Bact, or C complexes). Psoralen crosslinking revealed an interaction during/after step 1 between internal loop 1 of the U5 snRNA, and intron nucleotides immediately downstream of the branchpoint. Using the experimentally derived structural constraints, we generated a model of the RNA network of the step 1 spliceosome, based on the crystal structure of a group II intron through homology modelling. The model is topologically consistent with current genetic, biochemical, and structural data. There is a [Have you seen?][1] (October 2013) associated with this Article. [1]: http://dx.doi.org/10.1038/emboj.2013.213
- Open Access
- 1 January 2012
- Published by Springer Nature in Nature Communications
- Vol. 3 (1) , 994
Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion
There is little quantitative information regarding how much splicing occurs co-transcriptionally in higher eukaryotes, and it remains unclear where precisely splicing occurs in the nucleus. Here we determine the global extent of co- and post-transcriptional splicing in mammalian cells, and their respective subnuclear locations, using antibodies that specifically recognize phosphorylated SF3b155 (P-SF3b155) found only in catalytically activated/active spliceosomes. Quantification of chromatin- and nucleoplasm-associated P-SF3b155 after fractionation of HeLa cell nuclei, reveals that ~80% of pre-mRNA splicing occurs co-transcriptionally. Active spliceosomes localize in situ to regions of decompacted chromatin, at the periphery of or within nuclear speckles. Immunofluorescence microscopy with anti-P-SF3b155 antibodies, coupled with transcription inhibition and a block in splicing after SF3b155 phosphorylation, indicates that post-transcriptional splicing occurs in nuclear speckles and that release of post-transcriptionally spliced mRNA from speckles is coupled to the nuclear mRNA export pathway. Our data provide new insights into when and where splicing occurs in cells.
- 1 January 2012
- Published by Springer Nature in Nature Communications
- Vol. 3 (1) , 994
Open AccessPost-transcriptional spliceosomes are retained in nuclear speckles until splicing completion
There is little quantitative information regarding how much splicing occurs co-transcriptionally in higher eukaryotes, and it remains unclear where precisely splicing occurs in the nucleus. Here we determine the global extent of co- and post-transcriptional splicing in mammalian cells, and their respective subnuclear locations, using antibodies that specifically recognize phosphorylated SF3b155 (P-SF3b155) found only in catalytically activated/active spliceosomes. Quantification of chromatin- and nucleoplasm-associated P-SF3b155 after fractionation of HeLa cell nuclei, reveals that ~80% of pre-mRNA splicing occurs co-transcriptionally. Active spliceosomes localize in situ to regions of decompacted chromatin, at the periphery of or within nuclear speckles. Immunofluorescence microscopy with anti-P-SF3b155 antibodies, coupled with transcription inhibition and a block in splicing after SF3b155 phosphorylation, indicates that post-transcriptional splicing occurs in nuclear speckles and that release of post-transcriptionally spliced mRNA from speckles is coupled to the nuclear mRNA export pathway. Our data provide new insights into when and where splicing occurs in cells.
- Open Access
- 11 May 2006
- Published by Springer Nature in The EMBO Journal
- Vol. 25 (11) , 2475-2486
Proximity of conserved U6 and U2 snRNA elements to the 5′ splice site region in activated spliceosomes
Major structural changes occur in the spliceosome during its catalytic activation, which immediately precedes the splicing of pre‐mRNA. Whereas changes in snRNA conformation are well documented at the level of secondary RNA–RNA interactions, little is known about the tertiary structure of this RNA–RNA network, which comprises the spliceosome's catalytic core. Here, we have used the hydroxyl‐radical probe Fe‐BABE, tethered to the tenth nucleotide (U+10) of the 5′ end of a pre‐mRNA intron, to map RNA–RNA proximities in spliceosomes. These studies revealed that several conserved snRNA regions are close to U+10 in activated spliceosomes, namely (i) the U6 snRNA ACAGAG‐box region, (ii) portions of the U6 intramolecular stem‐loop (U6‐ISL) including a nucleotide implicated in the first catalytic step (U74), and (iii) the region of U2 that interacts with the branch point. These data constrain the relative orientation of these structural elements with respect to U+10 in the activated spliceosome. Upon conversion of the activated spliceosome to complex C, the accessibility of U6‐ISL to hydroxyl‐radical cleavage is altered, suggesting rearrangements after the first catalytic step.
- 11 May 2006
- Published by Springer Nature in The EMBO Journal
- Vol. 25 (11) , 2475-2486
Open AccessProximity of conserved U6 and U2 snRNA elements to the 5′ splice site region in activated spliceosomes
Major structural changes occur in the spliceosome during its catalytic activation, which immediately precedes the splicing of pre‐mRNA. Whereas changes in snRNA conformation are well documented at the level of secondary RNA–RNA interactions, little is known about the tertiary structure of this RNA–RNA network, which comprises the spliceosome's catalytic core. Here, we have used the hydroxyl‐radical probe Fe‐BABE, tethered to the tenth nucleotide (U+10) of the 5′ end of a pre‐mRNA intron, to map RNA–RNA proximities in spliceosomes. These studies revealed that several conserved snRNA regions are close to U+10 in activated spliceosomes, namely (i) the U6 snRNA ACAGAG‐box region, (ii) portions of the U6 intramolecular stem‐loop (U6‐ISL) including a nucleotide implicated in the first catalytic step (U74), and (iii) the region of U2 that interacts with the branch point. These data constrain the relative orientation of these structural elements with respect to U+10 in the activated spliceosome. Upon conversion of the activated spliceosome to complex C, the accessibility of U6‐ISL to hydroxyl‐radical cleavage is altered, suggesting rearrangements after the first catalytic step.